HK99593A - Pharmaceutical compositions containing a dideoxynucleoside - Google Patents

Pharmaceutical compositions containing a dideoxynucleoside Download PDF

Info

Publication number
HK99593A
HK99593A HK995/93A HK99593A HK99593A HK 99593 A HK99593 A HK 99593A HK 995/93 A HK995/93 A HK 995/93A HK 99593 A HK99593 A HK 99593A HK 99593 A HK99593 A HK 99593A
Authority
HK
Hong Kong
Prior art keywords
dideoxycytidine
tablet
dideoxynucleoside
ingredients
formulations
Prior art date
Application number
HK995/93A
Other languages
German (de)
English (en)
Inventor
Whaijen Soo
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of HK99593A publication Critical patent/HK99593A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (1)

  1. Application de 2' ,3'-didésoxycytidine à la préparation d'un médicament pour fournir une unité posologique contenant de la 2',3'-didésoxycytidine en une quantité suffisante aux fins d'administration à un sujet à raison de 0,001 à 0,05 mg/kg/jour pour la prévention ou le traitement du SIDA.
HK995/93A 1987-09-18 1993-09-23 Pharmaceutical compositions containing a dideoxynucleoside HK99593A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9825587A 1987-09-18 1987-09-18

Publications (1)

Publication Number Publication Date
HK99593A true HK99593A (en) 1993-09-30

Family

ID=22268410

Family Applications (1)

Application Number Title Priority Date Filing Date
HK995/93A HK99593A (en) 1987-09-18 1993-09-23 Pharmaceutical compositions containing a dideoxynucleoside

Country Status (13)

Country Link
EP (1) EP0307914B1 (fr)
JP (1) JP2648329B2 (fr)
KR (1) KR960014991B1 (fr)
AT (1) ATE78693T1 (fr)
AU (1) AU616427B2 (fr)
CA (1) CA1334166C (fr)
DE (1) DE3873232T2 (fr)
HK (1) HK99593A (fr)
HU (1) HUT47856A (fr)
IE (1) IE62191B1 (fr)
IL (1) IL87776A (fr)
PH (1) PH24796A (fr)
ZA (1) ZA886107B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
EP0355245A1 (fr) * 1988-08-26 1990-02-28 Michel Vandevelde Utilisation d'agents d'inhibition de la réverse-transcriptase des rétrovirus
CA2054771A1 (fr) * 1989-05-15 1990-11-16 Hiroaki Mitsuya Methode de traitement de l'hepatite
EP0472595A4 (en) * 1989-05-15 1992-07-08 Us Commerce Method of treatment of hepatitis
ES2060373T3 (es) * 1990-04-19 1994-11-16 Previsan Sa Derivados azoicos, compuestos farmaceuticos y desinfectantes que los contienen y su utilizacion contra el sida.
US5585367A (en) * 1990-04-19 1996-12-17 Previsan S.A. Method of treating humans and animals infected with viruses of the retrovirus group
JP2593409Y2 (ja) * 1992-12-02 1999-04-12 エスエムケイ株式会社 キーボードスイッチ
DE4419256A1 (de) * 1994-06-01 1995-12-07 Rau Freiherr Von Nagell Helmut Verwendung von intravenös applizierbarem Eisen zur Therapie von Tumorerkrankungen und/oder Infektionskrankheiten
DE4421159C1 (de) * 1994-06-20 1995-08-24 Thomas Bruns Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8801303A1 (es) * 1985-05-15 1987-12-16 Wellcome Found Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
GB8512542D0 (en) * 1985-05-17 1985-06-19 Atomic Energy Authority Uk Improved cutting edges
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
WO1987001283A1 (fr) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition du caractere infectieux et de l'effet cytopathique du htlv-iii/lav in vitro par la 2',3'-dideoxycytidine

Also Published As

Publication number Publication date
IE882836L (en) 1989-03-18
DE3873232D1 (de) 1992-09-03
KR890004705A (ko) 1989-05-09
PH24796A (en) 1990-10-30
JPS6483020A (en) 1989-03-28
IE62191B1 (en) 1994-12-28
EP0307914A2 (fr) 1989-03-22
AU2234588A (en) 1989-03-23
JP2648329B2 (ja) 1997-08-27
EP0307914A3 (en) 1989-08-09
DE3873232T2 (de) 1992-12-03
CA1334166C (fr) 1995-01-31
HUT47856A (en) 1989-04-28
EP0307914B1 (fr) 1992-07-29
IL87776A (en) 1994-01-25
ZA886107B (en) 1989-04-26
KR960014991B1 (ko) 1996-10-23
ATE78693T1 (de) 1992-08-15
AU616427B2 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
US4879277A (en) Antiviral compositions and methods
JPH0215523B2 (fr)
EP0307914B1 (fr) Composition pharmaceutique contenant un didéoxynucléoside
Whitley Therapeutic approaches to varicella-zoster virus infections
US4438138A (en) Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
EP0629400B1 (fr) Compositions contenant de l'idebenone pour le traitement de la maladie d'Alzheimer
US5028595A (en) Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
Jacobson et al. Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet
WO2023128427A1 (fr) Composition pharmaceutique comprenant de l'acide poly-gamma-glutamique en tant que principe actif pour prévenir, atténuer ou traiter une maladie infectieuse à coronavirus (sars-cov-2)
KR0143410B1 (ko) B형 비루스성 간염치료용 제약학적 조성물
CA2238770A1 (fr) Utilisation d'une combinaison de pentoxifylline et d'interferons de type i pour le traitement de la sclerose en plaques
US4666889A (en) Method for combatting viral infections
JPS63267781A (ja) 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
US5955498A (en) Agent for prophylaxis and therapy of diseases
US4303658A (en) Antiviral pyrazolopyrazines
JP2007297412A (ja) ヒト・ヘルペスウイルス−８の治療に対するペンシクロビルの使用
EP0338404A1 (fr) Emploi de l'acétate de mégestrol pour obtenir une composition pharmaceutique de traitement de la cachexie liée au sida
EP0245954B1 (fr) Utilisation de l'étodolac pour diminuer les niveaux sanguins d'acide urique
US4971977A (en) Anti-viral pharmaceutical compositions
US4230725A (en) Antiviral agent
US4537908A (en) Herpes II treatment
JPH05170646A (ja) 抗エイズウイルス剤
Collignon et al. Neurological toxicity associated with vidarabine (adenine arabinoside) therapy
JPH06199674A (ja) 日和見感染症の治療・予防に関する医薬
EP0488041A2 (fr) Une composition pharmaceutique contre l'infection de cytomégalovirus

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080914